ArticleCancer immunology, immunotherapy : CII2021

Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer.

Damien J Zanker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.